These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1839077)

  • 21. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
    Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
    Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.
    Romani N; Inaba K; Puré E; Crowley M; Witmer-Pack M; Steinman RM
    J Exp Med; 1989 Mar; 169(3):1153-68. PubMed ID: 2522496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
    Hara T; Jung LK; Fu SM
    J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors.
    Smith KG; Austyn JM; Hariri G; Beverley PC; Morris PJ
    Eur J Immunol; 1986 May; 16(5):478-86. PubMed ID: 2938973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
    Cole MS; Anasetti C; Tso JY
    J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.
    Bibollet-Ruche F; McKinney BA; Duverger A; Wagner FH; Ansari AA; Kutsch O
    J Virol; 2008 Oct; 82(20):10271-8. PubMed ID: 18667496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties.
    Bolt S; Routledge E; Lloyd I; Chatenoud L; Pope H; Gorman SD; Clark M; Waldmann H
    Eur J Immunol; 1993 Feb; 23(2):403-11. PubMed ID: 8436176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
    Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
    Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody.
    Bertotto A; Gerli R; Lanfrancone L; Crupi S; Arcangeli C; Cernetti C; Spinozzi F; Rambotti P
    Cell Immunol; 1990 May; 127(2):247-59. PubMed ID: 2139363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell activation by monoclonal antibodies directed to different epitopes on the human T cell receptor/CD3 complex: evidence for two different modes of activation.
    Schlitt HJ; Kurrle R; Wonigeit K
    Eur J Immunol; 1989 Sep; 19(9):1649-55. PubMed ID: 2477253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A human TCR-Ig chimeric protein used to generate a TCR alpha chain variable region-specific mAb.
    Bismuth G; Gouy H; Mariuzza RA; Vaquero C; Theodorou I; Debre P
    Mol Immunol; 1990 Nov; 27(11):1127-36. PubMed ID: 2147229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
    J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
    J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
    Stohl W; Linker-Israeli M
    Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
    Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.